CCR2 antagonist peptides
The invention relates to a peptide comprising the following amino acid sequence Thr-Phe-Leu-Lys (SEQ ID NO: 17) or Thr-Phe-Leu-Lys-Cys (SEQ ID NO: 1), useful as a CCR2 non-competitive antagonist peptide.
1. A peptide that consists of LGTFLKC (SEQ ID NO:3).
2. The peptide of claim 1 , wherein all or part of the amino acids are in D configuration.
3. The peptide of claim 1 , wherein all or part of the amino acids are in L configuration.
4. A compound that comprises a peptide as defined in claim 1 linked to at least one non-peptide moiety.
5. The compound of claim 4 , wherein the non-peptide moiety is polyethylene gycol.
6. A pharmaceutical composition, comprising the peptide as defined in claim 1 , in association with a pharmaceutically acceptable carrier.